BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Policy

  First Algenex CrisBio®-based vaccine submitted to European Medicines Agency

  Potential approval would validate the use of Algenex’ CrisBio® technology for the manufacture of recombinant subunit vaccines

  October 15, 2019

   · 

  2 min read
• 

  Pneumagen Demonstrates Preclinical Proof-of-Concept in Oncology for Neumonco, a Novel Carbohydrate Binding Module

  Pneumagen Ltd, focused on treating infectious disease and oncology by targeting the human glycome, announced promising in vivo data in oncology from a novel Carbohydrate Binding Module generated from its proprietary GlycoTarge™ platform.

  October 15, 2019

   · 

  2 min read
• 

  Business

  GeoVax Presenting at Upcoming October 2019 European Scientific Conferences

  GeoVax Labs, Inc. announced that it will be represented during presentations at the following upcoming European scientific conferences.

  October 15, 2019

   · 

  3 min read
• Business

  Magnetic Insight Announces the Appointment of David Panzarella as Chief Commercial Officer

  Magnetic Insight, Inc., the leader in Magnetic Particle Imaging solutions, announced that David Panzarella has been appointed as the company’s Chief Commercial Officer.

  October 15, 2019

   · 

  2 min read